Junge Zhang - 01 Apr 2026 Form 4 Insider Report for Ocugen, Inc. (OCGN)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
02 Apr 2026, 21:26:46 UTC
Prior SEC filing
09 Jun 2025
Next SEC filing
15 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Shankar Musunuri, attorney-in-fact

Key filing fact

Junge Zhang filed Form 4 for Ocugen, Inc. (OCGN) on 02 Apr 2026.

Key facts

  • This page summarizes Junge Zhang's Form 4 filing for Ocugen, Inc. (OCGN).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 02 Apr 2026, 21:26.

Change

  • Previous filing in this sequence was filed on 09 Jun 2025.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001790205 Primary reporting owner

Zhang Junge

Relationship
Director
Address
C/O OCUGEN, INC., 11 GREAT VALLEY PARKWAY, MALVERN
Signature
/s/ Shankar Musunuri, attorney-in-fact
Signature date
02 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

OCGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+15,000
Change %
+1.3%
Price
$0.5100*
Shares after
1,180,182
Date
01 Apr 2026
Ownership
Direct
OCGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+112,205
Change %
+9.5%
Price
$0.4600*
Shares after
1,292,387
Date
01 Apr 2026
Ownership
Direct
OCGN transaction

Common Stock

Options Exercise

Transaction value
Shares
+66,929
Change %
+5.2%
Price
$1.42*
Shares after
1,359,316
Date
01 Apr 2026
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

OCGN transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
Shares
-15,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
15,000
Exercise price
$0.5100
Footnotes
F1
OCGN transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
Shares
-112,205
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
112,205
Exercise price
$0.4600
Footnotes
F2
OCGN transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
Shares
-66,929
Change %
-100%
Price
$0.000000*
Shares after
0
Date
01 Apr 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
66,929
Exercise price
$1.42
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

The option, initially representing a right to purchase 54,000 shares, vested and became exercisable in equal installments over three years commencing on January 2, 2020.

Footnote F2

The option, representing a right to purchase 112,205 shares, vested and became exercisable on June 9, 2024.

Footnote F3

The option, representing a right to purchase 66,929 shares, vested and became exercisable on June 28, 2025.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .